New York, NY -- (SBWIRE) -- 01/29/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: SUPERVALU INC (NYSE:SVU), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Companhia de Saneamento Basico (ADR) (NYSE:SBS), Dynavax Technologies Corporation (NASDAQ:DVAX)
SUPERVALU INC (NYSE:SVU) showed a volume of 3.34 million shares by the end of last trade whereas the average volume of the stock remained 4.74 million shares. The stock opened the session at $6.11 but then moved to $6.12. At that price, the stock showed a positive performance of 0.49%. SUPERVALU INC. (SUPERVALU) is a United States grocery channel. It operates in three segments: Retail food, Save-A-Lot and Independent business. The Company leverages its distribution operations by providing wholesale distribution and logistics and service solutions to its independent retail customers through its Independent business segment.
Will SVU Continue To Move Higher? Find Out Here
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) opened the session at $6.89 and closed the session at $8.04. The stock showed a positive performance of 17.03% in previous trading session. Traded with volume of 3.32 million shares in the prior session and the average volume of the stock remained 1.47 million shares. Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France.
For How Long IDIX will fight for Profitability? Read This Trend Analysis report
Companhia de Saneamento Basico (ADR) (NYSE:SBS) opened the session at $9.39 and closed the session at $9.23. The stock showed a negative performance of -0.86% in previous trading session. Traded with volume of 3.30 million shares in the prior session and the average volume of the stock remained 1.91 million shares. The beta of the stock remained 1.54. Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SABESP) is a Brazil-based company which provides basic and environmental sanitation services in the domestic market.
Why Should Investors Buy SBS After the Recent Fall? Just Go Here and Find Out
Dynavax Technologies Corporation (NASDAQ:DVAX) the stock advanced 3.95% and finished the session at $1.84. Traded with volume of 3.29 million shares in the prior session and the average volume of the stock remained 5.57 million shares. The beta of the stock remained 2.83. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases. Its product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than licensed vaccines.
Will DVAX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)